ALLMedicine™ Cardiogenic Shock Center

Aug 7th, 2022 - "Enrolling patients in Cardiogenic shock Trials: are we missing someone? Insights from Italian Alt Shock-2 Registry".|2022|Pappalardo F,Tavazzi G,Savonitto S,Moricci N,|

Aug 7th, 2022 - Elevated serum angiopoietin-2 levels in patients with acute myocardial infarction-related cardiogenic shock with and without intra-aortic balloon pump as well as acute decompensated heart failure are associated with short-term mortality. However, ...

Aug 6th, 2022 - Protocolized team-based care has been shown to improve outcomes in cardiogenic shock (CS) in patients with end-stage heart failure (ESHF). This study tested the hypothesis that protocolized care improves survival by reducing multi-organ dysfunctio...

Aug 6th, 2022 - This article highlights the most relevant emergency medicine (EM) pharmacotherapy publications indexed in 2021. A modified Delphi approach was utilized for selected journals to identify the most impactful EM pharmacotherapy studies via the GRADE s...

Aug 5th, 2022 - Vasoactive treatment is a cornerstone in treating hypoperfusion in cardiogenic shock following acute myocardial infarction (AMICS). The purpose was to compare the achievement of treatment targets and outcome in relation to vasoactive strategy in A...

Aug 3rd, 2022 - The PACCS trial is a multicenter, randomized, parallel group, adaptive trial that will test the hypothesis that early invasive hemodynamic assessment (within 6 hours of randomization) and ongoing management with a PAC decreases in-hospital mortali...

Jul 28th, 2022 - The current study hypothesizes that The SCS treatment with the icor kit provides sufficient support for cardiocirculatory function as indicated by a significant lactate reduction 24 hours on SCS treatment versus before treatment start. Patients wi...

Jul 27th, 2022 - Study Objectives: To determine the effect of early left atrial septostomy versus conventional approach(left atrial septostomy only in cases of significant changes due to left ventricular end-diastolic pressure increase) in patients who received ve...

Jul 27th, 2022 - This registry is a non-interventional, multicentre, retrospective cohort study in patients with acute myocardial infarction undergoing PCI after CRP, ventilated and/or with cardiogenic shock. The study is purely observational; data will be documen...

Jul 26th, 2022 - Scientific background - Venoarterial extracorporeal membrane oxygenation (VA-ECMO) is used more and more frequently in patients with acute myocardial infarction (AMI) and refractory cardiogenic shock despite the absence of high level scientific ev...

Jul 26th, 2022 - Another observational study has questioned whether Impella ventricular assist pumps (Abiomed) should be used in patients with acute myocardial infarction (MI) complicated by cardiogenic shock (CS), at least compared with an intra-aortic balloon pu...

Jul 13th, 2022 - This transcript has been edited for clarity. Matthew F. Watto, MD: Welcome back to The Curbsiders. I'm Dr Matthew Watto, here with my great friend, Dr Paul Nelson Williams. Paul, how are you doing today? Paul N. Williams, MD: I'm great. We're talk...

May 26th, 2022 - Takotsubo syndrome occurs much more frequently in women than it does in men, but men are much more likely to die from it, according to the results of a new study. In an analysis of almost 2,500 patients with Takotsubo syndrome (TSS) who were enrol...

May 25th, 2022 - Takotsubo syndrome occurs much more frequently in women than it does in men, but men are much more likely to die from it, according to the results of a new study. In an analysis of almost 2,500 patients with Takotsubo syndrome (TSS) who were enrol.

Apr 21st, 2022 - This article was originally published in French on Medscape. WASHINGTON, DC — By giving Alain Cribier, MD, PhD, professor emeritus at Rouen University Hospital in Rouen, France, the Presidential Citation Award, the American College of Cardiology C...